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Abstract Using conserved fingerprints in the glycosyltransfer- 
ase (GTase) domain of high-molecular-weight penicillin-binding 
proteins (PBP), a gene (mgt) encoding a putative monofunctional 
glycosyltransferase has been identified in Haemophilus influen- 
zae and in other bacterial species. Here we report the cloning of 
the homologous Escherichia coli gene and show that the 
solubilised membrane fraction of E. coil cells overexpressing 
the mgt gene contain a significantly increased peptidoglycan 
synthesis activity. In contrast to the high-molecular-weight 
PBPs, this activity is not inhibited by Flavomycin. 
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1. Introduction 
The synthesis of a cell wall is one of the most intensively 
studied processes of bacterial metabolism. Efforts are directed 
mostly towards understanding of the last steps of peptidogly- 
can synthesis which take place in the periplasmic space and 
are therefore regarded as suitable physiological targets for 
antibiotics. In this compartment two major enzymatic activ- 
ities are responsible for the formation of peptidoglycan: (1) 
the glycosyltransferase (GTase) which polymerises the glycan 
strands using lipid-linked disaccharide-pentapeptide as sub- 
strate and (2) the transpeptidase (TPase) which cross-links 
the formed strands via their peptide chains. Transpeptidases 
are also known as penicillin-binding proteins (PBP), since pe- 
nicillin and other IMactam antibiotics were found to cova- 
lently bind to their active sites, thereby inhibiting their func- 
tion which eventually leads to cell lysis. In Escherichia coli the 
high-molecular-weight PBPs 1A, 1B, 2 and 3 are involved in 
various cellular processes uch as cell shape determination, 
cell elongation and cell division. Among these enzymes, 
PBP1A and PBP1B were shown to carry both glycosyltrans- 
ferase and transpeptidase activity [1]. These periplasmically 
located PBPs are bound to the cytoplasmic membrane via a 
N-terminal hydrophobic signal sequence. Their activities re- 
side in two different domains of the polypeptide: GTase is 
found in the N-terminal half of the protein, while the C-term- 
inal half carries the TPase activity and is therefore responsible 
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for penicillin-binding [2]. E. coli mutants lacking either 
PBP1A or PBP1B, but not both, are viable which shows 
that each of these PBPs can compensate for the absence of 
the other [3-5]. Since mutants lacking PBP1B retain only 10% 
of the peptidoglycan synthesis activity, the major peptidogly- 
can-synthesising activity is assigned to PBP1B [3,6]. The bi- 
functional nature of the high-molecular-weight PBPs 2 and 3 
is still controversial. While the TPase activity of both proteins 
was proven, the GTase activity could not be demonstrated 
unambiguously [7]. PBP2 in conjunction with the RodA pro- 
tein was shown to be involved in cell elongation; PBP3 to- 
gether with the FtsW protein is believed to play an important 
role during cell septation [8-11]. Low-molecular-weight PBPs, 
namely PBPs 4, 5 and 6, are monofunctional nd usually have 
a D,D-carboxypeptidase activity that is required for the ma- 
turation of the peptidoglycan and for the regulation of the 
level of cross-linking [12]. 
In the mid-1980s, monofunctional, non-penicillin-binding 
enzymes from different bacterial species were described that 
possess GTase activity. Hara and Suzuki [13] purified and 
characterised an E. coli enzyme of Mr 34000, which synthe- 
sised peptidoglycan from lipid-linked precursors. Enzymes 
with similar catalytic properties were also found in the 
Gram-positive Staphylococcus aureus, Micrococcus luteus [14] 
and Streptococcus pneumoniae [15]. It is noteworthy that these 
enzymes were shown to be responsible for the major part of 
the total in vitro GTase activity measured. So far, little atten- 
tion was paid to this new class of peptidoglycan-synthesising 
proteins. One reason for the fact that these enzymes were not 
investigated in more detail may be that such a GTase could be 
purified only from E. coli and only in very small quantities 
[13]. However, the present availability of complete bacterial 
genome sequences as well as the progress made in the hetero- 
logous overexpression and purification of bacterial proteins, 
may render them more accessible for functional and structural 
studies. Here we report the cloning of the E. coli mgt gene, of 
which the sequence shows significant homologies to well-con- 
served fingerprints found in the N-terminal GTase domain of 
the bifunctional PBPs. Furthermore, we show that overexpres- 
sion of the mgt gene leads to a significant increase in the rate 
of peptidoglycan synthesis in in vitro GTase assays, demon- 
strating for the first time that the mgt gene product indeed 
exhibits the assumed activity. 
In this paper, the term glycosyltransferase (GTase) de- 
scribes the glycan-synthesising polymerase activity of the 
high-molecular-weight PBPs and of the MGT protein. We 
deliberately avoided the term transglycosylase, which is con- 
fusing because it has been used in the literature to describe 
both glycan synthesising as well as glycan degrading enzymes. 
All rights reserved. 
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2. Materials and methods 
2.1 Cloning of mgt encoding the putative monofunctional GTase from 
Escherichia coli 
The monofunctional GTase of E. coli was identified by DNA se- 
quence data base searches using the conserved fingerprints indicated 
in Fig. 1 as search patterns. A homology search in the complete 
Haemophilus influenzae genome revealed the presence of an ORF 
(H10831) encoding a possible monofunctional GTase. A homologous 
ge~e was then found in the known E. coli genome sequence in the 72.2 
mia region. Primer 84/2 (5'-CGCGTGCTGGTTCTGGCeatAT- 
GAGT AAAAGCCGCTTAAC-Y) introducing by the three base sub- 
sti', utions (lower case letters) a NdeI site (bold letters) and primer 84/ 
10 (5'-CACTTCGCGCGAAGCTTAATCCAGCTG-3') containing a
natural HindIII site were used to amplify mgt from E. coli strain 
W::ll0 (ATCC 27325). The PCR reaction was performed with Taq 
DNA-Polymerase and reagents from Boehringer Mannheim (Man- 
nh~,qm, Germany) with the following cycle protocol: melting at 95°C 
fo~ 1 min, annealing at 60°C for 1 min, and extension at 72°C for 
1 ~lin for a total of 20 cycles. The resulting 0.8 kb PCR product was 
digested with NdeI and HindlII, isolated and integrated into plasmid 
pDS56/RBSII,NdeI yielding plasmid pMGT. Plasmid pDS56/ 
RBSII,NdeI was derived from plasmid pDS56/RBSII,NcoI [16] by 
re~ lacing its NcoI site with a NdeI site and by eliminating the cat gene. 
2.Z. Expression of mgt in E. coli 
['he expression plasmid containing the putative monofunctional 
Gl'ase gene (pMGT1) was used to transform W3110 cells, which al- 
re:kdy contained plasmid pREP4 [16]. pREP4 harbours a neomycin/ 
ka lamycin cassette and the lacI repressor gene, which guarantees a 
vet y low basal expression of the cloned PCR product. For the expres- 
sic,n, W3110 cells bearing pMGT and pREP4 were grown in Super 
Medium (25 g bacto-tryptone, 15g bacto-yeast extract and 5 g NaC1 
pe~ litre) containing ampicillin (100 ~tg/ml) and kanamycin (25 I.tg/ml) 
to an OD600 of 0.6. The expression was then induced by the addition 
o1 isopropyl-I]-D-thiogalactopyranoside (IPTG) to a final concentra- 
ti~,n of 50 [,tM. The cells were grown for another 30 min, harvested by 
ce~Ltrifugation, washed with 20 mM Tris-HC1, pH 8.0 and stored at 
-10°C. Plasmid pDS781/RBSII-DHFRS, expressing the mouse dihy- 
dl )folate reductase gene [16] was used in the same expression system 
as vector control. 
2..  Preparation of solubilised membranes and determination of the 
peptidoglycan synthesis activity 
Wet packed cells (1 g) were suspended in 4 ml of disruption buffer 
(5~ mM Tris-HC1, pH 7.5, 1 mM MgCI2, 1 mM 1,4-dithiothreitol 
(13TT), 0.2 mM phenylmethylsulfonyl fluoride and traces of DNAse) 
ar.J disintegrated by two successive passages through a French Press 
chamber at 83 MPa. Whole cells and cell debris were removed by 
ce~ltrifugation at 15 000 ×g for 20 min, and the membrane vesicles 
w,:re sedimented by centrifugation at 200 000 X g for 1 h. The mem- 
bl me vesicles were resuspended in 1 ml of disruption buffer contain- 
in!; 2% Elugent (Calbiochem, La Jolla, CA), the extract incubated for 
1( min on ice and finally centrifuged for 40 min at 200 000 x g. The 
su 9ernatant (=Elugent extract) was either directly used for the deter- 
ruination of the peptidoglycan synthesis activity or stored in aliquots 
at -20°C, where it retains its glycan-polymerising activity without 
c~ asiderable loss for several freeze/thaw cycles. 
the radiolabelled lipid II precursor was prepared with E. coli mem- 
bl rues from UDP-N-acetyl-[14C]glucosamine (Amersham, Bucking- 
h~mshire, UK) essentially as described [13]. Peptidoglycan synthesis 
at ::ivities were determined in 50 ~tl reactions containing 50 mM 
PIPES, pH 6.1, 10 mM MgC12, 0.2 mM DTT, 1 mM ATP, 26.7% 
dimethylsulfoxide (DMSO), Elugent extract and 14C-labelled lipid II 
(6t)00 cpm, 14.2 pmol). The reaction was started by the addition of the 
laurelled compound and incubated for 30q50 min at room temperature. 
T:~e reaction mixtures were finally filtered through hydrophilic Dur- 
al~ore PVDF membranes (0.65 ~un; Millipore, Bedford, MA), on 
wtich synthesised peptidoglycan was retained, while the unincorpo- 
ra ed 14C-labelled lipid II precursor was washed out by three succes- 
si', e washing steps with 0.4 M ammonium acetate in methanol. The 
filter-bound radioactivity was determined by liquid scintillation count- 
ing. Flavomycin (a mixture of different moenomycins), which was 
used for inhibition studies, was from Hoechst (Frankfurt, Germany). 
I~ control experiments demonstrating the effect of Flavomycin on 
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glycan polymerisation of high-molecular-weight PBPs, E. coli 
SP1026 cells (ED3184 AponB:: Spc r, [4]) lacking PBP1B were trans- 
formed with plasmid pMC56-PBPIb, which was shown to function- 
ally overexpress the E. coli homologue PBP1B from Citrobacterfreun- 
dii (Lbchle et al., submitted). 
2.4. Molecular cloning methods and analytical procedures 
General DNA manipulations and cloning procedures were per- 
formed according to described protocols [17]. DNA sequence analysis 
was performed according to the dideoxynucleotide chain termination 
method [18] using a Taq DyeDeoxy terminator cycle sequencing kit 
and the model 377A DNA sequencer f om Applied Biosystems. The 
protein content of samples was determined as described by Bradford 
[19] and SDS/polyacrylamide g l electrophoresis was performed ac- 
cording to Laemmli [20]. 
3. Results and discussion 
Based on characteristic fingerprints found in the N-terminal 
GTase domains of bifunctional PBPs (Fig. 1) we discovered in 
Haemophilus influenzae an unassigned ORF  (HI0831, EMBL/  
GenBank/DDJB, accession umber L42023) encoding a puta- 
tive monofunctional GTase. Sequence comparison with the 
known E. coli genomic sequences also led to the identification 
of an unassigned ORF  (ORF242; EMBL/GenBank/DDJB,  
accession number U18997) of which the product may carry 
a putative GTase activity. Similarly, a homologous MGT was 
identified in the known genomic sequence of Staphylococcus 
aureus (EMBL/GenBank/DDJB, accession number L19300) 
and in Alcaligenes eutrophus (EMBL/GenBank/DDJB, acces- 
sion number Z22737; Paik, J., Jendrossek, D. and Haken- 
beck, R., in preparation). Recently, Spratt and coworkers 
found by a different approach other putative monofunctional 
GTases [21]. 
In order to elucidate the enzymatic activity of this protein, 
we amplified the E. coli mgt gene (ORF 242) by PCR and 
cloned it in an expression vector. Although the expression 
system used usually leads to a high expression of the desired 
gene, a fractionation of the cells into cytoplasmic and mem- 
brane fraction was necessary to clearly visualise the resulting 
product by SDS-PAGE (Fig. 2). The sequence of the gene 
showed an uncleavable N-terminal membrane-anchor suggest- 
ing that the protein would be membrane-bound. A band of 
the expected size (27 kDa) appeared in the membrane fraction 
of W3110 cells expressing the putative monofunctional GTase. 
Such a band could not be detected in control cells, which 
contained pDS781/RBSI I -DHFRS. Interestingly, the host 
cells (W3110) expressing mgt stopped growing, but did not 
lyse, immediately after induction with IPTG, indicating that 
the gene product was deleterious for the cells. Therefore, the 
cells were grown for only half an hour after induction. 
Much more relevant han the synthesis of this monofunc- 
tional enzyme was the demonstration of its peptidoglycan 
synthesis activity. The assays to measure the peptidoglycan 
synthesis activity of this monofunctional enzyme were per- 
formed using solubilised membranes and lipid II, the specific 
substrate of the known periplasmic E. coli GTases. Since we 
expressed the mgt gene in wild-type W3110 cells, it was im- 
portant to keep the interference of the other peptidoglycan- 
synthesising enzymes, namely PBPs 1A and 1B, as low as 
possible. PBP1B, which is the major peptidoglycan-synthesis- 
ing protein of E. coli, has its pH optimum between pH 7.5 and 
8.0 [13]. On the other hand, the only monofunctional GTase 
in E. coli described so far [13] was shown to have a pH 
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Fig. 1. Alignment of the amino acid sequences of the N-terminal domains of the indicated high-molecular-mass PBPs from E. coli (Eco), H. in- 
fluenzae (Hin), Mycobacterium leprae (Mle), Bacillus subtilis (Bsu), Streptococcus pneumoniae (Spn), Staphylococcus aureus (Sau) and the new 
putative monofunctional g ycosyltransferases (MGTs). The fingerprints used for the search of the MGTs are indicated by the shadowed boxes 
(x = any amino acid). Numbers indicate the N- and C-terminal residues of the listed proteins. 
optimum between pH 6.0 and 6.5. We therefore decided to 
determine glycan polymerisation activity at a rather acidic 
pH. In Fig. 3 the peptidoglycan synthesis activities of induced 
E. coli W3110/pMGT1 cells are compared with those of the 
same cells that carry plasmid pDS781/RBSII-DHFRS. The 
results clearly demonstrate that the expression of the cloned 
gene leads to a significantly increased glycan polymerisation 
activity. Furthermore, subsequent incubation of the synthe- 
sised peptidoglycan with lysozyme led to an almost complete 
loss of filter-bound radioactivity (data not shown), indicating 
that the polymerised glycan chains serve as substrate for ly- 
sozyme. Glycan polymerisation by the synthesised gene prod- 
uct showed a pH dependence, the pH optimum being between 
pH 6.0 and 6.5. On the other hand, peptidoglycan-synthesis- 
ing activity of W3110/pDS781/RBSII-DHFRS increased with 
increasing pH, which is a result of the fact that PBP1B be- 
comes active under more alkaline conditions. The initial velo- 
city of polymerisation was about 6.0 pmol/mg protein per 
min, which is three orders of magnitude lower than the spe- 
cific activity of the glycan polymerase described by Hara and 
Suzuki [13]. One must take into account, however, that the 
activity determined here was performed with a detergent ex- 
tract which is also presumed to contain peptidoglycan hydro- 
lysing enzymes. 
An interesting property of the synthesised monofunctional 
GTase results from inhibition assays performed in the pres- 
ence of Flavomycin. This phosphoglycolipid antibiotic is 
known to prevent glycosyl transfer, acting probably as a sub- 
strate analogue of lipid II [22]. As expected, peptidoglycan 
synthesis of W3110/pDS781/RBSII-DHFRS cells was severely 
impaired in the presence of low (0.2 ktg/ml) Flavomycin con- 
centrations. In contrast, the polymerisation activity of cells 
expressing mgt was not significantly affected by Flavomycin 
(Fig. 3). Since the inhibitory mechanism of Flavomycin relies 
on the stoichiometric binding to the GTase domain, the fail- 
ure of this antibiotic to inhibit glycan polymerisation by the 
MGT enzyme may have been due to the overexpression of
mgt. However, as shown in Fig. 4A, even after a 100-500- 
fold dilution of the Elugent extract from mgt expressing cells, 
this inhibition was negligible and probably affected only the 
low polymerisation activity deriving from PBPs 1A and IB 
under the applied conditions. In a control experiment, PBP1B 
from Citrobacterfreundii, which is 94% identical to the E. coli 
homologue, was synthesised in E. coli SP1026 cells lacking a 
PBP1B background (L6chle et al., submitted) and the effect of 
M. Di Berardino et al./FEBS Letters 392 (1996) 184-188 187 
1 2 3 4 M 
kDa 
97.4 
66.2 
45.0 
31.0 
21.5 
Fir. 2. Expression of mgt in t£ coB. W3110/pREP4 cells carrying 
ext~ression plasmids pDS781/RBSII-DHFRS (lanes 1 and 3) or 
plX~,GT (lanes 2 and 4) were grown to an OD600 = 0.6, the expression 
of the cloned genes was induced with 50 pM IPTG and the cells 
wc'e grown for another 30 min. The cytoplasmic (lanes 1 and 2) 
anJ membrane fractions (lanes 3 and 4) were analysed by SDS- 
PAGE. 30 ktg of protein (25 I.tg in lane 2) were loaded on a 10% 
S[:~S/Polyacrylamide gel which was stained with Coomassie blue. 
Tt e arrow indicates the synthesised MGT product. M =molecular 
m.~ss marker. 
Flivomycin on the glycan polymerisation activity was ana- 
ly-ed. Although in these cells the heterologous enzyme was 
ox erproduced and highly active, a 10-fold dilution of the cor- 
re-.ponding Elugent extract already allowed Flavomycin (0.2 
~t~/ml) to inhibit the glycan-polymerising activity by 50%, and 
a further 5-fold dilution of the extract resulted in complete 
in',libition of glycan polymerisation by Flavomycin (Fig. 4B). 
AL present, the reasons remain speculative for why Flavomy- 
cit is a potent inhibitor of the GTase activity of PBPs 1A and 
I l ~, while it does not affect the GTase activity of MGT. Acting 
as a substrate analogue or possibly as a transition state ana- 
logue, Flavomycin is believed to compete with lipid II for 
bi~lding to the active site of GTases. Differential affinities of 
monofunctional nd bifunctional GTases for lipid II and Fla- 
wmycin might explain the observed ifferences in the effect of 
F avomycin on the two types of peptidoglycan polymerising 
G l'ases. The failure of Flavomycin to inhibit the mgt product 
a,, well as the pH optimum of the enzyme in the acidic pH 
r~ age minimise the background peptidoglycan synthesis of the 
hl:gh-molecular-weight PBPs and represent an easy way to 
m :asure the GTase activity of MGT in wild-type cells. Evi- 
d~ nee for the presence of peptidoglycan-degrading hydrolases 
i~ the Elugent extracts is provided by the fact that most of the 
n:dioactivity was incorporated for the 5- and 10-fold diluted 
s~, mples. This can be explained by a complete polymerisation 
o: the lipid-linked precursor, which is fastest for the undiluted 
s~ mple, offering thereby more time to the endogenous hydro- 
la;es, during the 1 h incubation, for the subsequent peptido- 
gl ¢can degradation. 
In summary, the data presented here confirm the presence 
o~ a membrane-bound monofunctional GTase in E. coli that 
p,,lymerises glycan chains using lipid II as substrate. This 
el zyme activity can now be assigned to the mgt gene product. 
However, it is not clear whether the cloned and expressed mgt 
g~ne encodes the monofunctional g ycan polymerase described 
by Hara and Suzuki [13]. While the enzyme purified by Hara 
and Suzuki has a molecular weight of 34 kDa, the mgt gene 
encodes a product of 27.3 kDa, which corresponds well to the 
overexpressed protein observed by SDS-PAGE in this study. 
A discrepancy of a few kDa may appear in the acceptable 
range of inaccuracy of the gel electrophoresis method and is 
frequently encountered when apparent and calculated molecu- 
lar weights of, mostly hydrophobic, proteins are compared. 
However, there is a considerable difference in Mr between 
the GTase presented in this study and the enzyme purified 
by Hara and Suzuki, taking into account that the observed 
Mr of both proteins derive from similar SDS-PAGE analyses. 
Furthermore, the purified glycan polymerase of Hara and 
Suzuki [13] was shown to be stimulated by Ca 2+ ions. Prelim- 
inary experiments with MGT did not confirm those results. 
On the other hand, both monofunctional enzymes have pH 
optima in the range between pH 6.0 and 6.5 and are not 
inhibited by Flavomycin, indicating that these enzymes pos- 
sess some similar characteristics. More information on the 
nature of the glycan polymerase purified by Hara and Suzuki 
would require the determination f the N-terminal amino acid 
sequence of this enzyme. 
At present, the functional role of the MGT enzyme in the 
E. coli cell cycle remains unclear. Expression of mgt seems to 
be transcriptionally and translationally coupled to a gene en- 
coding a putative 'cy cross-reacting protein' of unknown func- 
tion [23]. Whether these genes are expressed under laboratory 
growth conditions remains to be determined. Since PBP 1A / 
1B double mutants are not viable [3-5] we must assume that 
either the mgt gene is not or only poorly expressed, or that the 
product polymerised by the monofunctional GTase, i.e., non- 
crosslinked glycan strands, is not the right substrate for trans- 
peptidation by the high-molecular-weight PBPs 2 and 3. 
Further studies are envisaged (1) to analyse the polymerisa- 
tion product formed by purified MGT enzyme (excluding 
thereby the cross-linking PBPs), and (2) to assess the possible 
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Fig. 3. Peptidoglycan synthesis by Elugent extracts using 14C-la- 
belled lipid II precursor and inhibition by Flavomycin. Elugent ex- 
tracts of W3110/pDS781/RBSII-DHFRS (118 gg protein) or W3110/ 
pMGT cells (65 p.g protein) were prepared as described under Sec- 
tion 2 and incubated for 50 min in 50 mM PIPES buffer of the in- 
dicated pH containing 14C-labelled lipid II (14.2 pmol, ~ 6000 cpm) 
in absence or presence of 0.2 gg/ml Flavomycin. Polymerised pepti- 
doglycan was determined as filter-bound radioactivity by scintilla- 
tion counting. 
188 M. Di Berardino et al./FEBS Letters 392 (1996) 184-188 
A 
~4000 [" 
'i 3000 
"~ 2000 
~ 1000 
0 
o g o ° g g o 
dilution 
~6000 ! 
i 4000 
"~ 3000 
2000 
 ,ooo 
o o g g g g 
dilution 
Fig. 4. Effect of Flavomycin on peptidoglycan synthesis of serially 
diluted Elugent extracts. Elugent extracts of W3110/pMGT (A) or 
SP1026/pMC56-PBPlb (B) were diluted as indicated in 50 mM 
PIPES, pH 6.1, 1 mM MgC12 containing 2% Elugent and peptido- 
glycan polymerisation was determined after 1 h incubation in ab- 
sence (light bars) or presence of 0.2 gg/ml Flavomycin (dark bars) 
as described under Section 2. 
function of this enzyme in the cell cycle by determining ene 
expression levels and by deletion mutagenesis. 
Independent of the function of the enzyme described in this 
paper, monofunctional GTases may become very important 
for the design of new antibiotics. The increasing resistance of 
pathogenic bacteria against 13-1actam antibiotics demands the 
establishment of new targets, such as the GTase activity of 
MGTs and PBPs. The presence of major non-PBP related 
glycan polymerase activities in pathogenic Gram-positive bac- 
teria like S. aureus and S. pneumoniae [14,15] emphasizes the 
importance of this new class of enzymes and should incite 
further studies in this direction. Another reason why MGTs 
deserve more consideration relies on the fact that until now no 
structural data are available for the bifunctional high-molecu- 
lar-weight PBPs, a class of enzymes which has been under 
investigation for more than 20 years. The smaller MGTs 
might prove to be more accessible for structural investiga- 
tions. 
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